Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Papua New Guinea
Papua New Guinea: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 41.0% in 2024. ▲ Rising
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Papua New Guinea, 2015–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
In 2024, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Papua New Guinea stood at 41.0%. That is the highest value across all 10 years on record.
Compared with earlier readings it is up 41.4% on the previous year and up 105.0% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Papua New Guinea peaked at 41.0% in 2020 and was at its lowest, 20.0%, in 2015.
Papua New Guinea ranks 142nd of 146 countries on this measure, in the bottom quarter.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Papua New Guinea, year by year
| Year | % | Change |
|---|---|---|
| 2015 | 20.0% | — |
| 2016 | 20.0% | +0.0% |
| 2017 | 36.0% | +80.0% |
| 2018 | 35.0% | -2.8% |
| 2019 | 35.0% | +0.0% |
| 2020 | 41.0% | +17.1% |
| 2021 | 34.0% | -17.1% |
| 2022 | 38.0% | +11.8% |
| 2023 | 29.0% | -23.7% |
| 2024 | 41.0% | +41.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 29.2% | 20.0% | 36.0% | 5 |
| 2020s | 36.6% | 29.0% | 41.0% | 5 |
Countries ranked near Papua New Guinea
More health data for Papua New Guinea
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3741 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,127 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,501 deaths (2100)
- Population ages 60-64, female, annual growth rate 5.8 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0121 units per person (2025)
- Population ages 60-64, male, annual growth rate 3.53 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0133 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Papua New Guinea?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Papua New Guinea was 41.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Papua New Guinea?
- The highest recorded value was 41.0% in 2020.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Papua New Guinea?
- The lowest recorded value was 20.0% in 2015.
- How does Papua New Guinea rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Papua New Guinea ranks 142nd out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Papua New Guinea?
- Over the last ten years it is up 105.0%. The long-run trend across the full record is rising.
- Where does this Papua New Guinea data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.